Why AstraZeneca PLC (AZN) is One of the Best Immunotherapy Stocks to Buy According to Hedge Funds

In a abstracted development, AstraZeneca PLC (NASDAQ:AZN) announced connected February 13 the afloat results from the affirmative Phase III KALOS and LOGOS trials, showing that the company’s Breztri Aerosphere exhibited statistically important and clinically meaningful improvements successful patients with uncontrolled asthma compared with dual-combination inhaled corticosteroid/long-acting beta2-agonist medicines: Symbicort, PT009, and the Symbicort and PT009 attraction groups combined. Breztri is simply a single-inhaler, fixed-dose triple-combination of ICS/LABA and a long-acting muscarinic antagonist.

AstraZeneca PLC (NASDAQ:AZN) further reported that Breztri besides showed clinically meaningful reductions successful the annualised complaint of terrible asthma exacerbations versus ICS/LABA medicines successful patients with oregon without a caller asthma exacerbation successful the pooled investigation of KALOS and LOGOS. In addition, determination were nary caller information oregon tolerability signals identified for Breztri successful KALOS oregon LOGOS.

AstraZeneca PLC (NASDAQ:AZN) is simply a biopharmaceutical institution that explores, develops, manufactures, and commercializes medicine medicines. It supplies its products and services to specialty and superior attraction physicians, and is progressive successful exploring caller immuno-oncology attraction approaches. AstraZeneca PLC (NASDAQ:AZN) distributes its products and services done section typical offices and distributors.

While we admit the imaginable of AZN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.